jamiebell

58 POSTS 0 COMMENTS

Cerenovus to unveil new data and showcase stroke care innovations at...

cerenovus stroke care
Cerenovus, a neurovascular firm that forms part of The Johnson & Johnson Medical Devices Companies, will showcase its latest innovations in stroke care at...

Treatment of asymptomatic carotid bifurcation occlusive disease and potential role of...

carotid disease stenting
Peter A Schneider (San Francisco, USA) discusses the role stenting can play, alongside the existing best medical therapy, in treating asymptomatic carotid disease patients. Best...

Omniscient Neurotechnology launches Quicktome brain-mapping platform following FDA clearance

quicktome omniscient neurotechnology
Omniscient Neurotechnology has received US Food and Drug Administration (FDA) 510(k) clearance for Quicktome—a digital brain-mapping platform that allows neurosurgeons to visualise and understand...

Omniscient Neurotechnology raises AUD$40 million in Series B financing

Omniscient Neurotechnology
Omniscient Neurotechnology, a Sydney-based brain-mapping technology company, has announced the completion of a AUD$40 million Series B financing round. The funding will allow Omniscient...

Nevro announces FDA approval of 10kHz high-frequency SCS therapy for painful...

nevro senza
Nevro has announced receipt of US Food and Drug Administration (FDA) approval for its Senza system for the treatment of chronic pain associated with...

ASA highlights value of comprehensive, patient-centred primary care after stroke

primary stroke care ASA
In a new scientific statement entitled “Primary Care of Adult Patients After Stroke”, the American Stroke Association (ASA)—a division of the American Heart Association...

How stimulation is changing the future of mental health treatment

tdcs mental health treatment
Daniel Månsson (Flow Neuroscience, Malmö, Sweden) outlines the benefits held by transcranial direct-current stimulation (tDCS) in the treatment of depression—and how clinical evidence supporting...

Brainomix launches AI stroke software across Poland under POLKARD initiative

brainomix poland
Brainomix has deployed its flagship artificial intelligence (AI)-based e-Stroke software across the majority of the largest comprehensive stroke centres in Poland, allowing the company...

BlueWind Medical enrols 100th patient in OASIS study of Renova iStim...

renova istim
BlueWind Medical, a company making neuromodulation medical devices for the treatment of overactive bladder, has announced that the 100th patient has been enrolled in...

Repeated clot retrieval attempts linked to poorer functional outcome in acute...

repeated clot retrieval stroke
Repeated clot retrieval attempts are associated with an increased rate of emboli to new territory (ENT) and greater infarct growth—resulting in poorer functional outcomes...

Philips enrols first patient in WE-TRUST stroke study to assess new...

WE-TRUST study philips
Royal Philips has announced that the first patient has been enrolled in the WE-TRUST (Workflow optimisation to reduce time to endovascular reperfusion for ultra-fast...

Robocath, Rennes University Hospital partner with Philips France to research stroke...

robocath stroke research
Robocath and Rennes University Hospital have announced they are launching a co-development research programme using robotics to improve treatments for stroke patients. With the...

Insightec announces approval of Exablate Neuro focused ultrasound platform in Singapore

exablate neuro singapore
Insightec has announced approval of its Exablate Neuro platform by the Health Sciences Authority (HSA) in Singapore. The Exablate Neuro (Exablate 4000) platform uses...

Men and women respond equally well to spinal cord and DRG...

spinal cord stimulation men women
In a study intended to explore gender differences in patients with failed back surgery syndrome (FBSS) or chronic visceral pain, men and women have...

Neuros Medical gains FDA Breakthrough Device designation for Altius nerve block...

neuros medical altius
Neuros Medical has received Breakthrough Device designation from the US Food and Drug Administration (FDA) for the use of its novel, high-frequency nerve block...

NeuroNews’ top 10 most popular stories of June 2021

neuronews top 10
Fresh evidence on the differences between directional and omnidirectional deep brain stimulation (DBS), as well as regulatory approvals for a new reperfusion catheter and...

Viz.ai receives CE mark to bring AI-powered stroke care software to...

viz.ai ce mark
Viz.ai has been awarded a CE mark for its artificial intelligence (AI)-powered stroke care software, affirming its conformity with European health, safety and environmental...

Mainstay Medical launches implantable restorative neurostimulation system in USA

mainstay reactiv8
Mainstay Medical has announced the limited US commercial launch of ReActiv8, its implantable restorative neurostimulation system to treat intractable chronic low back pain. The...

Flow diverter study with virtual participants “as effective as traditional clinical...

virtual flow diverter trials
A study involving virtual participants—rather than real patients—was “as effective as traditional clinical trials” in evaluating the treatment of brain aneurysms using a flow...

New Stroke Association report to “shine a light” on stroke care’s...

stroke association priorities
The Stroke Association has announced the top areas of research that need to be prioritised to improve stroke care. The announcement of these priorities—which...

Epipole joins €1.1 million AI project to diagnose intracranial pressure

epipole
Video retinal imaging company Epipole has announced it has begun working on a €1.1 million collaborative project to develop a technology solution for the...

Penumbra receives FDA clearance for RED 62 reperfusion catheter

penumbra red 62
Penumbra has announced US Food and Drug Administration (FDA) 510(k) clearance and commercial availability of the RED 62 reperfusion catheter—the latest addition to the...

Stroke and heart condition patients want virtual healthcare to continue post...

virtual stroke care
After speaking with experts, reviewing current evidence, surveying people living with stroke or a heart condition, and funding a telephone poll of Canadians, the...

Sensome’s AI-powered stroke guidewire granted FDA Breakthrough Device designation

sensome
Sensome has announced its Clotild Smart Guidewire System—designed to improve the treatment of ischaemic stroke patients—has been granted a Breakthrough Device designation by the...

Neuromodulation device for treating MS-related gait deficit receives FDA authorisation

pons fda approval
Cambridge Consultants and Helius Medical Technologies have confirmed their “groundbreaking" Portable Neuromodulation Stimulator (PoNS) device—developed for the short-term treatment of gait deficit due to...

Data from 1,000 aneurysms indicate Pipeline Embolization Device is safe and...

pipeline embolization device
The endovascular treatment of intracranial aneurysms using the Pipeline Embolization Device (PED; Medtronic) has been deemed safe and effective following a study involving data...

Medtronic announces FDA approval of recharge-free Vanta spinal cord stimulation implant

medtronic vanta
Medtronic has received US Food and Drug Administration (FDA) approval for Vanta—a high-performance, recharge-free implantable neurostimulator (INS) with a device life that can be...

Benefits found in directional DBS compared to omnidirectional stimulation for Parkinson’s...

directional dbs
Directional deep brain stimulation (DBS) has demonstrated benefits over omnidirectional DBS for the treatment of Parkinson’s disease in the largest prospective study in this...

Mitchell Elkind

mitchell elkind
Mitchell Elkind is a professor of Neurology and Epidemiology at Columbia University Irving Medical Center, and chief of the Division of Neurology Clinical Outcomes Research and Population...

FDA approves “first-of-its-kind” SenSight Directional Lead System for DBS therapy

sensight
Medtronic has announced US Food and Drug Administration (FDA) approval and first US implants of the SenSight Directional Lead System, which is used...

New algorithm could enable next-generation deep brain stimulation devices

next-generation dbs devices
By delivering small electrical pulses directly to the brain, deep brain stimulation (DBS) can ease tremors associated with Parkinson's disease or help relieve chronic...

Vesalio secures Class A funding to bolster stroke treatment portfolio

vesalio series a funding
Vesalio has successfully secured a Class A financing round. The company claims this funding will be utilised to support its ongoing US Investigational Device...

Higher incidence of severe stroke found in COVID-19 patients

covid-19 severe stroke
Among people who have strokes and COVID-19, there is a higher incidence of severe stroke as well as a higher incidence of stroke in...

NeuroNews’ top 10 most popular stories of May 2021

neuronews top 10
New industry partnerships, the potential for energy savings in neuromodulation and the contentious topic of vertebral artery stenting were among the top stories that...

Avicenna.AI receives CE mark for AI tool to assess stroke severity

stroke severity assessment ai
Medical imaging AI specialist Avicenna.AI has received CE mark certification for its CINA ASPECTS AI tool for stroke severity assessment. CINA ASPECTS automatically processes...

Clinical improvements seen following transvenous paraspinal vein embolisation for CSF hypotension

csf hypotension
A case series to assess transvenous paraspinal vein embolisation of cerebrospinal fluid (CSF)-venous fistulas—a novel treatment approach for spontaneous intracranial hypotension (SIH)—has resulted in...

RapidAI unveils prehospital solution to optimise cross-team workflow and improve patient...

RapidAI
RapidAI has announced the launch of its Rapid prehospital workflow solution for stroke, which optimises coordination between emergency medical services (EMS) providers and hospital...

Livestreamed procedures close distance between clinicians and trainees during pandemic

livestreamed surgeries
Phil Taussky outlines a simple yet effective livestreaming platform that holds benefits for neurosurgeons during the ongoing COVID-19 crisis. One of the challenges faced by...

HeMo Bioengineering receives China’s NMPA approval for Afentta aspiration catheter

hemo bioengineering afentta
HeMo Bioengineering, a Singapore-based medical device company with a focus on treating stroke patients, has announced that its Afentta intracranial thrombectomy aspiration catheter—a product...

Prevention based on first stroke cause can reduce risk of subsequent...

aha stroke prevention guidelines
Identifying the cause of a stroke or transient ischaemic attack (TIA)—sometimes called a “mini-stroke”—can lead to specific prevention strategies to reduce the risk of...

Noninferiority of thrombectomy alone further demonstrated in acute ischaemic stroke treatment

mechanical thrombectomy alone
The noninferiority of mechanical thrombectomy alone—compared to mechanical thrombectomy plus intravenous tissue plasminogen activator (IV-tPA)—for the treatment of acute ischaemic stroke has been demonstrated...

Study shows “major energy savings” can be achieved in spinal cord...

spinal cord stimulation chronic pain
The results of the HALO (High and low frequency options) study, which are published online in the scientific journal Neuromodulation: Technology at the Neural...

Chordate Medical receives CE mark to treat chronic migraine with neuromodulation...

chordate medical
Chordate Medical has received a CE marking that permits its Kinetic Oscillation Stimulation (KOS) technology to be marketed, sold and used for the treatment...

Medtronic, Viz.ai partner to bring “lifesaving” AI platform for stroke to...

viz.ai medtronic
Medtronic and Viz.ai have announced they are extending their successful US partnership to distribute Viz.ai’s "lifesaving" artificial intelligence (AI) software platform for stroke to...

First annual World Stroke Thrombectomy Day to be announced by SVIN...

world stroke thrombectomy day
The Society of Vascular and Interventional Neurology (SVIN) Mission Thrombectomy 2020+ Initiative (MT2020+) will announce the first annual World Stroke Thrombectomy Day at the...

Vesalio initiates new FDA stroke study following “milestone” VITAL trial enrolment

vesalio
US medical device company Vesalio has announced the start of enrolment in the Vesalio CLEAR study—an acute ischaemic stroke FDA investigational device exemption (IDE)...

rTMS found to be “well-accepted” for therapeutic use in psychiatric populations

rtms therapy georgia stillianesis
Psychiatric populations perceive the therapeutic use of repetitive transcranial magnetic stimulation (rTMS) for mental health conditions to be beneficial, safe, and no more dangerous...

Perfuze announces CE mark and treats first patients with Millipede 088...

perfuze millipede 088
Neurovascular medical device company Perfuze has announced that the first five acute ischaemic stroke patients have been treated with its Millipede 088 clot aspiration...

Perflow Medical announces first clinical use of Stream17 Dynamic Neurothrombectomy Net

perflow medical stream17 device
Perflow Medical has announced the first successful clinical use of its Stream17 Dynamic Neurothrombectomy Net—a lower profile device designed to effectively treat haemorrhagic and...

CX 2021: Stenting should be reserved for the extracranial vertebral arteries...

vertebral artery stenting
Stenting is something that, for now at least, should be considered in the extracranial vertebral arteries only—and not the intracranial arteries—for symptomatic atherosclerotic stenosis,...

First US ischaemic stroke patients treated with Rapid Medical’s novel clot...

rapid medical TIGERTRIEVER
The first US patients have been treated with the FDA-cleared TIGERTRIEVER revascularisation device (Rapid Medical). TIGERTRIEVER is the first physician-adjustable stent retriever, according to...

IpsiHand System: New device for facilitating stroke rehabilitation gains FDA approval

IpsiHand System
The US Food and Drug Administration (FDA) has authorised marketing of a new device indicated for use in patients aged 18 and older undergoing...

Case report indicates 3D black blood vessel wall imaging can predict...

dr mohd fandi black blood vessel wall imaging
The early findings from a case report have highlighted the potential held by 3D black blood vessel wall post-contrast imaging to predict the outcomes...

Medtronic and Surgical Theater to provide first real-time AR platform for...

complex cranial procedures
Medtronic will partner with American health technology firm Surgical Theater to provide the first augmented reality (AR) platform for use in real time during...

UK charity funds “world-first” study into long-term COVID-19 impact on stroke

stroke association priorities
Leading UK charity the Stroke Association is funding what it claims will be the world’s first study to determine the long-term impact of COVID-19...

First patient enrolled in MindRhythm trial to assess LVO stroke diagnostic...

lvo stroke diagnosis mindrhythm
MindRhythm, a US medical technology company focused on preventing neurological injury in stroke, has announced the enrolment of the first patient in a multicentre...

Thrombolysis versus thrombectomy: Honours even between basilar occlusion treatments in CX...

basilar artery occlusion treatments
Thrombolysis is considered as effective as mechanical thrombectomy for the treatment of basilar artery occlusion (BAO)—despite existing evidence on both intervention options being limited....

Medtronic gains FDA approval to trial implantable tibial neuromodulation device

medtronic implantable tibial neuromodulation device
Medtronic has announced approval from the US Food and Drug Administration (FDA) to proceed with an investigational device exemption (IDE) trial to evaluate its...